Cargando…

Immunomodulation of AT III in septic disease

Detalles Bibliográficos
Autores principales:	Leonhardt, U, Lehmann, I, Sack, U, Engelmann , L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1999
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301802/ http://dx.doi.org/10.1186/cc474

Ejemplares similares

T-cell-subpopulations in septic patients
por: Leonhardt, U, et al.
Publicado: (2001)

Platelet function and inflammatory markers in septic patients
por: Leonhardt, U, et al.
Publicado: (1999)

Procalcitonin in autoimmune disease with sepsis
por: Leonhardt, U, et al.
Publicado: (2001)

The changes in platelet function in SIRS, sepsis and MODS -- a tight connection to the changes in the immune and hemostatic system
por: Leonhardt, U, et al.
Publicado: (2000)

Perspectives of personalized immunomodulation in dentistry
por: Gratchev, Alexei, et al.
Publicado: (2014)

Induction of a rapid progessive cartilage destruction in SCID mice by intraarticular application of a murine fibroblast like cell line
por: Sack, U, et al.
Publicado: (2001)

Gene therapy of destructive arthritis in SCID mice
por: Sack, U, et al.
Publicado: (2003)

Reduction of cartilage destruction in a rapid progressive arthritis model in SCID mice
por: Sack, U, et al.
Publicado: (2002)

Immunological monitoring in ICU patients: immunomodulation for compromised host
por: Takeyama, N, et al.
Publicado: (2001)

Procalcitonin helps to discriminate between septic and non-septic underlying disease at admission in ICU
por: Lepousé, C, et al.
Publicado: (2000)

Increased concentrations of procollagen type III peptide in the evolution of septic phenomenon. An indicator of organ damage and fibrinogenesis? (Preliminary data results)
por: Mavrommatis, A, et al.
Publicado: (2001)

Does O(2) availability determine hepatic metabolic activity in septic shock?
por: Reinelt, H, et al.
Publicado: (1997)

ARDS: dramatic rises in arterial PO(2 )with the 'open lung' approach
por: Engelmann, L, et al.
Publicado: (1997)

Is β-adrenergic receptor stimulation crucial for splanchnic O(2) availability in septic shock?
por: Reinelt, H, et al.
Publicado: (1997)

Effects of Antithrombin III on body cavity effusions, fluid balance, colloid osmotic pressure and hemodynamics in porcine septic shock
por: Cobas Meyer, M, et al.
Publicado: (2000)

Disturbance of energy metabolism in acute septic cardiomyopathy: decreased activities of the complexes I and II of the mitochondrial respiratory chain and phosphofructokinase
por: Trumbeckaite, S, et al.
Publicado: (1997)

Preload assessment in septic shock
por: Donati, A, et al.
Publicado: (2000)

Hypocalcemia in children with septic shock
por: Buysse, CMP, et al.
Publicado: (2001)

Cellular mechanisms of acute septic cardiomyopathy: cardiodepressive profiles of endotoxin, tumor necrosis factor α and interleukin-1 in the cardiomyocyte
por: Müller-Werdan, U, et al.
Publicado: (1997)

The role of the adrenergic system in septic encephalopathy
por: Davies, DC, et al.
Publicado: (2001)

Myocardial cell injury in septic shock
por: Rodrigues, MG, et al.
Publicado: (2003)

Control of DIC after administration of ATIII in ICU septic patients
por: Vasiliagou, S, et al.
Publicado: (2001)

Severity stratification of septic shock according to noradrenaline requirement
por: Hernández, G, et al.
Publicado: (2001)

Severity stratification of septic shock according to noradrenaline requirement
por: Hernández, G, et al.
Publicado: (2001)

Elevated levels of adhesion molecules in septic patients with pre-existing coronary artery disease
por: Wittich, R, et al.
Publicado: (2000)

Terlipressin in the treatment of catecholamine resistant septic shock
por: Auzinger, GM, et al.
Publicado: (2002)

Septic shock etiology in kidney transplant recipients
por: De Marco, FVC, et al.
Publicado: (2002)

Determinants of natriuretic peptides in early septic shock
por: Witthaut, R, et al.
Publicado: (1998)

Ultrasound detection of septic jugular vein thrombosis
por: Kobilica, Nina, et al.
Publicado: (2012)

Role of decisive markers in diagnosis and outcome of patients with septic shock
por: Rizk, A, et al.
Publicado: (2000)

Heart failure impairs vasomotor functions of the mesenteric bed after cardiopulmonary bypass
por: Szabó, G, et al.
Publicado: (2001)

Microcirculatory blood flow in the gastrointestinal tract during early septic shock
por: Hiltebrand, L, et al.
Publicado: (1998)

Effects of granulocyte-colony stimulating factor (G-CSF) prophylaxis in high risk patients (ASA III and IV) with colorectal cancer on perioperative cytokine levels, complications and global quality of life
por: Torossian, A, et al.
Publicado: (2002)

Platelets and platelet-activating factor acetylhydrolase in septic patients
por: Ruβwurm, S, et al.
Publicado: (1999)

Plasmafiltration in septic shock: a review of 15 cases
por: Campos, P, et al.
Publicado: (2003)

Neutrophil apoptosis, phagocytosis and oxidative metabolism in septic patients
por: Martins, PS, et al.
Publicado: (2001)

Pulmonary lactate production in septic patients with and without ARDS
por: Silva, E, et al.
Publicado: (2001)

Identification of diagnostic criteria of septic complications in children with neutropenia
por: Furmanchuk, DA, et al.
Publicado: (2003)

Mobile septic intra-atrial masses in premature infants
por: Serafim, AP, et al.
Publicado: (2003)

Effect of dopexamine on CO(2) -gradients and splanchnic energy balance in septic shock
por: Kiefer, P, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_b2gt6bqggbaeb5bis25g814og0